Phytoestrogens and breast cancer –promoters or protectors?
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The majority of breast cancers are oestrogen dependent and in postmenopausal women the supply of oestrogens in breast tissue is derived from the peripheral conversion of circulating androgens. There is, however, a paradox concerning the epidemiology of breast cancer and the dietary intake of phytoestrogens that bind weakly to oestrogen receptors and initiate oestrogen-dependent transcription. In Eastern countries, such as Japan, the incidence of breast cancer is approximately one-third that of Western countries whilst their high dietary intake of phytoestrogens, mainly in the form of soy products, can produce circulating levels of phytoestrogens that are known experimentally to have oestrogenic effects. Indeed, their weak oestrogenicity has been used to advantage by herbalist medicine to promote soy products as a natural alternative to conventional hormone replacement therapy (HRT). Such usage could increase in light of recent evidence that long-term HRT usage may be associated with an increased risk of breast cancer with a consequent reduction in prescription rates. So, are phytoestrogens safe as a natural alternative to HRT and could they be promoters or protectors of breast cancer? If they are promoters, then we must assume that it is due to their oestrogenic effect. If they are protectors, then other actions of phytoestrogens, including their ability to inhibit enzymes that are responsible for converting androgens and weak oestrogens into oestradiol, must be considered. This paper addresses these questions by reviewing the actions of phytoestrogens on oestrogen receptors and key enzymes that convert androgens to oestrogens in relation to the growth of breast cancer cells. In addition, it compares the experimental and epidemiological evidence pertinent to the potential beneficial or harmful effects of phytoestrogens in relation to the incidence/progression of breast cancer and their efficacy as natural alternatives to conventional HRT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“Jang et al. (1997) reported that resveratrol inhibited a number of events associated with the initiation, promotion, and progression of cancer.”
BackgroundInteraction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269 · cited 1×
“That said, the ligand-binding cavity in the E domain is highly conserved in the two receptors (Kuiper et al. 1996, Mosselman et al. 1996).”
BackgroundIntegration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Steroid sulfatase: molecular biology, regulation, and inhibition
Reed, M. J., Purohit, A., Woo, L. W. L., Newman, S. P., & Potter, B. V. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0003 · Cited by 524
Soy, isoflavones, and breast cancer risk in Japan
Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., & Tsugane, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.906 · Cited by 391 · cited 2×
“Thus, they are both antagonists in breast tissue but agonists in bone, while only raloxifen is a pure antagonist in the uterus (Yamamoto et al. 2003).”
BackgroundResultRhéaume, E., Lachance, Y., Zhao, H.-F., Breton, N., Dumont, M., Launoit, Y. D., Trudel, C., Luu-The, V., Simard, J., & Labrie, F. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1147 · Cited by 362 · cited 1×
“There are two isoforms, 1 and 2; the latter being mainly expressed in the adrenal glands and gonads and type 1 being expressed in the placenta and other tissues, including skin and breast, where it is considered mainly to convert DHEA to androstene-dione (Rheaume et al. 1991).”
BackgroundReflections on the Discovery and Significance of Estrogen Receptor β
Koehler, K. F., Helguero, L. A., Haldosén, L.-A., Warner, M., & Gustafsson, J.-A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0027 · Cited by 360
Kao, Y. C., Zhou, C., Sherman, M., Laughton, C. A., & Chen, S. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.9810685 · Cited by 338
Estrogen—the Good, the Bad, and the Unexpected
Simpson, E. R., Misso, M., Hewitt, K. N., Hill, R. A., Boon, W. C., Jones, M. E., Kovacic, A., Zhou, J., & Clyne, C. D. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0020 · Cited by 266 · cited 1×
“…by the fact that extragonadal sites, including breast, brain, muscle, skin, bone, and adipose tissue can synthesize potent androgens and oestrogens from relatively inactive circulating steroid precursors derived from the adrenal cortex and to a much lesser extent the ovaries (Simpson et al. 2005).”
Background
Cited by
Zaineddin, A. K., Buck, K., Vrieling, A., Heinz, J., Flesch-Janys, D., Linseisen, J., & Chang-Claude, J. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.683227 · Cited by 90
Richter, D., Abarzua, S., Chrobak, M., Vrekoussis, T., Weissenbacher, T., Kuhn, C., Schulze, S., Kupka, M. S., Friese, K., Briese, V., et al. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.797000 · Cited by 37
“Especially the sulphatase/17β-HSD1 pathway has been reported as equally important to estradiol production (23), contributing to the high local estradiol excess mainly seen in postmenopausal women (24).”
BackgroundThe role of soy and soy isoflavones on women’s fertility and related outcomes: An update
Rizzo, G., Feraco, A., Storz, M. A., & Lombardo, M. (2022) · Journal of Nutritional Science · doi:10.1017/jns.2022.15 · Cited by 34
Metadata
- Authors
- Rice, S., & Whitehead, S. A.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2006-12
- Volume
- 13
- Issue
- 4
- Pages
- 995-1015
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2132069091
- Cited by
- 191
- References
- 16
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phytoestrogens and breast cancer –promoters or protectors? https://app.cochat.ai/papers/10.1677/erc.1.01159
- The paper
- Rice, S., & Whitehead, S. A. (2006). Phytoestrogens and breast cancer –promoters or protectors? Endocrine-Related Cancer. https://doi.org/10.1677/erc.1.01159
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.